Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.40 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11673299 | 0.81 | AKT1 (0.40) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL9596280 | 0.81 | AKT1 (0.40) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL1076032 | 0.81 | AKT1 (0.40) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL11673293 | 0.81 | AKT1 (0.40) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL6438770 | 0.79 | AKT1 (0.39) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL727277 | 0.79 | AKT1 (0.39) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL476634 | 0.79 | MAOA (0.53) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL11048295 | 0.79 | AKT1 (0.39) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL9723351 | 0.79 | AKT1 (0.39) | MAOAMAOBHDAC1HDAC2AKT1 | |
| SCHEMBL11048275 | 0.79 | AKT1 (0.39) | MAOAMAOBHDAC1HDAC2AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113423777-B | Resin composition for optical material, optical film and display device | DIC株式会社 | 2023-03-24 | — | — | CN | claimed |
| CN-114539459-A | Solid-phase synthesis carrier and preparation method and application thereof | 西安蓝晓科技新材料股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114539458-A | Porous resin applied to solid phase synthesis and preparation method thereof | 西安蓝晓科技新材料股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-113423777-A | Resin composition for optical material, optical film and display device | DIC株式会社 | 2021-09-21 | — | — | CN | claimed |
| WO-2020162259-A1 | RESIN COMPOSITION FOR OPTICAL MATERIAL, OPTICAL FILM, AND DISPLAY DEVICE | DIC株式会社 | 2020-08-13 | — | — | WO | claimed |
| US-8802745-B2 | Porous resin bead and method for producing nucleic acid using the same | NITTO DENKO CORPORATION (JP) | 2014-08-12 | — | — | US | claimed |
| US-8653152-B2 | Porous resin bead and method for producing nucleic acid using the same | NITTO DENKO CORPORATION (JP) | 2014-02-18 | — | — | US | claimed |
| EP-1081492-B1 | PACKING MATERIAL FOR CHROMATOGRAPHY HAVING NOVEL CHARACTERISTIC AND METHOD FOR ISOLATION OF SUBSTANCE USING THE SAME | CELLSEED INC (JP) | 2009-01-14 | — | — | EP | claimed |
| US-5391667-A | Blend with ethynically unsaturated monomer having atleast one amine or amine-displaceable functionality and crosslinking agent; supports | ISIS PHARMACEUTICALS (US) | 1995-02-21 | — | — | US | claimed |
| US-12037422-B2 | Gel material | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2024-07-16 | — | — | US | disclosed |
| CN-114539458-B | Porous resin applied to solid phase synthesis and preparation method thereof | 西安蓝晓科技新材料股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-114539459-B | Solid phase synthesis carrier and preparation method and application thereof | 西安蓝晓科技新材料股份有限公司 | 2023-07-25 | — | — | CN | disclosed |
| US-11643389-B2 | Method for producing maleimide compound, compound and solid resin | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-11371015-B2 | Graft polymer, temperature-responsive substrate for cell culture using the same and production method therefor, as well as liquid chromatographic carrier having the novel graft polymer immomibilized thereon and liquid chromatographic method using the same | Sakai, Hideaki (JP) | 2022-06-28 | — | — | US | disclosed |
| EP-0400705-A1 | Filling material composition | STAMICARBON B.V. (NL) | 1990-12-05 | — | — | EP | disclosed |
| EP-0366190-A1 | Bismaleimide compositions | DSM N.V. (NL) | 1990-05-02 | — | — | EP | disclosed |
| EP-0334422-A2 | Spherical particles | STAMICARBON B.V. (NL) | 1989-09-27 | — | — | EP | disclosed |
| EP-0293112-A2 | Resin composition and electrical laminate obtained therefrom | Hitachi Chemical Co., Ltd. (JP) | 1988-11-30 | — | — | EP | disclosed |
| US-4473630-A | Liquid developer comprising aminoalkyl styrene polymer for electrostatic images | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-25 | — | — | US | disclosed |
| US-4097420-A | Method for preparation of macroporous amphoteric ion exchangers with highly crosslinked hydrophilic polymeric matrix | CESKOSLOVENSKA AKADEMIE VED (CS) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11643389-B2 | Method for producing maleimide compound, compound and solid resin | DAP3, MEP1A, ASS1 | MAOA 3088/4885MAOB 3790/4885HDAC1 134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.